<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00971750</url>
  </required_header>
  <id_info>
    <org_study_id>2-03-08-009</org_study_id>
    <nct_id>NCT00971750</nct_id>
  </id_info>
  <brief_title>Laparoscopic Versus Transabdominal Ultrasound in Morbidly Obese Patients</brief_title>
  <official_title>Comparison of Laparoscopic Ultrasound to Transabdominal Ultrasound for the Detection of Gallbladder Pathology in the Bariatric Surgical Population.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gundersen Lutheran Medical Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Gundersen Lutheran Health System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gundersen Lutheran Medical Foundation</source>
  <brief_summary>
    <textblock>
      The objective of this study is to prospectively compare laparoscopic ultrasound to
      transabdominal ultrasound for the detection of gallbladder pathology in obese patients
      presenting for laparoscopic gastric bypass. We hypothesize that laparoscopic ultrasound will
      be more sensitive and specific for cholelithiasis than transabdominal ultrasound in morbidly
      obese patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Asymptomatic cholelithiasis is a prevalent condition in obese patients presenting for
      bariatric surgery. Transabdominal ultrasound (TAU) remains the gold standard for detection of
      cholelithiasis. The sensitivity and specificity of transabdominal ultrasound for
      cholelithiasis reported in literature is between 88-97% and 97-99%, respectively. The ability
      to detect cholelithiasis with TAU in the obese population may be inhibited due to the
      presence of increased subcutaneous and visceral fat. Laparoscopic ultrasound (LU) has the
      potential to overcome these technical challenges. In an era of minimally invasive bariatric
      surgery, it has been suggested that routine preoperative ultrasound TAU be performed for the
      detection of cholelithiasis since intraoperative palpation is not feasible. We hypothesize
      that laparoscopic ultrasound will be more sensitive and specific for cholelithiasis than
      transabdominal ultrasound in morbidly obese patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2003</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cholelithiasis on Transabdominal Ultrasound Versus Laparoscopic Ultrasound.</measure>
    <time_frame>transabdominal measurements within 30 days prior to surgery; laparoscopic ultrasound measurements are completed intraoperatively</time_frame>
    <description>Number of patients with cholelithiasis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Polyps on Transabdominal and Laparoscopic Ultrasound</measure>
    <time_frame>6 years</time_frame>
    <description>Number of patients with polyps.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Common Bile Duct (CBD) Diameter Measured by Transabdominal Ultrasound Versus Laparoscopic Ultrasound.</measure>
    <time_frame>transabdominal measurements will be done within 30 days prior to surgery; laparoscopic ultrasound measurements are completed intraoperatively</time_frame>
    <description>Mean CBD diameter.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">253</enrollment>
  <condition>Cholelithiasis</condition>
  <condition>Ultrasonography</condition>
  <condition>Laparoscopic Gastric Bypass</condition>
  <arm_group>
    <arm_group_label>Ultrasound Study Group</arm_group_label>
    <description>Patients with no history of gallbladder surgery who are undergoing elective laparoscopic roux-en-Y gastric bypass that have consented to undergo a preoperative transabdominal ultrasound in addition to routine preoperative assessment for surgery.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Study population will consist of patients undergoing laparoscopic gastric bypass at a
        community-based teaching institution.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Morbidly obese patients undergoing elective laparoscopic roux-en-Y gastric bypass

        Exclusion Criteria:

          -  Prior history of gallbladder surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shanu N Kothari, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gundersen Lutheran Health System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gundersen Lutheran Health System</name>
      <address>
        <city>La Crosse</city>
        <state>Wisconsin</state>
        <zip>54601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Yang HL, Li ZZ, Sun YG. Reliability of ultrasonography in diagnosis of biliary lithiasis. Chin Med J (Engl). 1990 Aug;103(8):638-41.</citation>
    <PMID>2122943</PMID>
  </reference>
  <reference>
    <citation>Cronan JJ. US diagnosis of choledocholithiasis: a reappraisal. Radiology. 1986 Oct;161(1):133-4.</citation>
    <PMID>3532178</PMID>
  </reference>
  <reference>
    <citation>Shea JA, Berlin JA, Escarce JJ, Clarke JR, Kinosian BP, Cabana MD, Tsai WW, Horangic N, Malet PF, Schwartz JS, et al. Revised estimates of diagnostic test sensitivity and specificity in suspected biliary tract disease. Arch Intern Med. 1994 Nov 28;154(22):2573-81.</citation>
    <PMID>7979854</PMID>
  </reference>
  <reference>
    <citation>Einstein DM, Lapin SA, Ralls PW, Halls JM. The insensitivity of sonography in the detection of choledocholithiasis. AJR Am J Roentgenol. 1984 Apr;142(4):725-8.</citation>
    <PMID>6608231</PMID>
  </reference>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 3, 2009</study_first_submitted>
  <study_first_submitted_qc>September 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 4, 2009</study_first_posted>
  <results_first_submitted>March 23, 2012</results_first_submitted>
  <results_first_submitted_qc>May 29, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 2, 2012</results_first_posted>
  <last_update_submitted>June 29, 2012</last_update_submitted>
  <last_update_submitted_qc>June 29, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gundersen Lutheran Medical Foundation</investigator_affiliation>
    <investigator_full_name>Kara Kallies</investigator_full_name>
    <investigator_title>Advanced Research Associate, under direction of Shanu N. Kothari, MD, (PI)</investigator_title>
  </responsible_party>
  <keyword>ultrasonography</keyword>
  <keyword>gallbladder</keyword>
  <keyword>cholelithiasis</keyword>
  <keyword>laparoscopic</keyword>
  <keyword>gastric bypass</keyword>
  <keyword>obesity</keyword>
  <keyword>bariatric surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholelithiasis</mesh_term>
    <mesh_term>Cholecystolithiasis</mesh_term>
    <mesh_term>Gallstones</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Ultrasound Study Group</title>
          <description>Patients with no history of gallbladder surgery who are undergoing elective laparoscopic roux-en-Y gastric bypass that have consented to undergo a preoperative transabdominal ultrasound in addition to routine preoperative assessment for surgery.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="253"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="253"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Ultrasound Study Group</title>
          <description>Patients with no history of gallbladder surgery who are undergoing elective laparoscopic roux-en-Y gastric bypass that have consented to undergo a preoperative transabdominal ultrasound in addition to routine preoperative assessment for surgery.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="253"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="251"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43.5" spread="9.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="192"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="253"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Cholelithiasis on Transabdominal Ultrasound Versus Laparoscopic Ultrasound.</title>
        <description>Number of patients with cholelithiasis.</description>
        <time_frame>transabdominal measurements within 30 days prior to surgery; laparoscopic ultrasound measurements are completed intraoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Transabdominal Ultrasound</title>
            <description>Patients with no history of gallbladder surgery who are undergoing elective laparoscopic roux-en-Y gastric bypass that have consented to undergo a preoperative transabdominal ultrasound in addition to routine preoperative assessment for surgery.</description>
          </group>
          <group group_id="O2">
            <title>Laparoscopic Ultrasound</title>
            <description>Laparoscopic ultrasound is performed intraoperatively at the time of gastric bypass.</description>
          </group>
        </group_list>
        <measure>
          <title>Cholelithiasis on Transabdominal Ultrasound Versus Laparoscopic Ultrasound.</title>
          <description>Number of patients with cholelithiasis.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="253"/>
                <count group_id="O2" value="253"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61"/>
                    <measurement group_id="O2" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.763</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Common Bile Duct (CBD) Diameter Measured by Transabdominal Ultrasound Versus Laparoscopic Ultrasound.</title>
        <description>Mean CBD diameter.</description>
        <time_frame>transabdominal measurements will be done within 30 days prior to surgery; laparoscopic ultrasound measurements are completed intraoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Transabdominal Ultrasound</title>
            <description>Patients with no history of gallbladder surgery who are undergoing elective laparoscopic roux-en-Y gastric bypass that have consented to undergo a preoperative transabdominal ultrasound in addition to routine preoperative assessment for surgery.</description>
          </group>
          <group group_id="O2">
            <title>Laparoscopic Ultrasound</title>
            <description>Laparoscopic ultrasound is performed intraoperatively during gastric bypass</description>
          </group>
        </group_list>
        <measure>
          <title>Common Bile Duct (CBD) Diameter Measured by Transabdominal Ultrasound Versus Laparoscopic Ultrasound.</title>
          <description>Mean CBD diameter.</description>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="253"/>
                <count group_id="O2" value="253"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="1.28"/>
                    <measurement group_id="O2" value="3.7" spread="1.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Polyps on Transabdominal and Laparoscopic Ultrasound</title>
        <description>Number of patients with polyps.</description>
        <time_frame>6 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Transabdominal Ultrasound</title>
            <description>Patients with no history of gallbladder surgery who are undergoing elective laparoscopic roux-en-Y gastric bypass that have consented to undergo a preoperative transabdominal ultrasound in addition to routine preoperative assessment for surgery.</description>
          </group>
          <group group_id="O2">
            <title>Laparoscopic Ultrasound</title>
            <description>Laparoscopic ultrasound is performed intraoperatively at the time of gastric bypass.</description>
          </group>
        </group_list>
        <measure>
          <title>Polyps on Transabdominal and Laparoscopic Ultrasound</title>
          <description>Number of patients with polyps.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="253"/>
                <count group_id="O2" value="253"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Ultrasound Study Group</title>
          <description>Patients with no history of gallbladder surgery who are undergoing elective laparoscopic roux-en-Y gastric bypass that have consented to undergo a preoperative transabdominal ultrasound in addition to routine preoperative assessment for surgery.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="253"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="253"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Shanu Kothari</name_or_title>
      <organization>Gundersen Lutheran Health System</organization>
      <phone>608-775-2331</phone>
      <email>snkothar@gundluth.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

